Use of streptokinase instead of surgical interference for the treatment of urinary clot retention.
The value of streptokinase in treating 14 patients with bladder clot retention was studied. The fibrinolytic action of this proteolytic enzyme was successful in dissolving the clots in 13 of the 14 patients.
D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011470:Prostatic Hyperplasia / Q000150:complications; D012552:Schistosomiasis / Q000150:complications; D013300:Streptokinase / Q000627:therapeutic use*; D013927:Thrombosis / Q000188:drug therapy* / Q000209:etiology; D001745:Urinary Bladder Diseases / Q000188:drug therapy*; D001749:Urinary Bladder Neoplasms / Q000150:complications
D013300:Streptokinase